Skip to main content
Premium Trial:

Request an Annual Quote

SRA International Awarded $9.7M Task Order by NHLBI

NEW YORK (GenomeWeb News) – SRA International today announced a task order amounting to up to $9.7 million from the National Heart, Lung, and Blood Institute to provide "comprehensive" information technology support.

The task order is part of a $184 million blanket purchase agreement secured by the Fairfax, Va.-based firm with NHLBI, also announced today. That agreement covers services through 2017.

The task order is for five years and has a value of $9.7 million if all options are exercised, SRA said. SRA will support NHLBI's Information Technology and Applications Center. Specifically, it will provide support to NHLBI's databases, visualization, and scientific data analyses tools.

The company will additonally evaluate software alternatives to support information technology requirements associated with research, clinical, and administrative requirements within NHLBI's intramural and extramural programs.

SRA provides IT and other services to the US government and previously disclosed in 2010 a $15.5 million grant from the National Institute of Environmental Health Sciences to provide biological research and other related services for studies in the National Toxicology Program and a contract also in 2010 for up to $17.9 million from NIH to support The Cancer Genome Atlas project.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.